Imunon Inc (IMNN)
1.44
-0.02
(-1.37%)
USD |
NASDAQ |
May 31, 16:00
1.47
+0.03
(+2.08%)
After-Hours: 20:00
Imunon Free Cash Flow (Quarterly): -5.886M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -5.886M |
| December 31, 2023 | -3.772M |
| September 30, 2023 | -4.713M |
| June 30, 2023 | -6.949M |
| March 31, 2023 | -4.040M |
| December 31, 2022 | -5.052M |
| September 30, 2022 | -4.697M |
| June 30, 2022 | -5.583M |
| March 31, 2022 | -8.032M |
| December 31, 2021 | -5.114M |
| September 30, 2021 | -3.845M |
| June 30, 2021 | -2.713M |
| March 31, 2021 | -4.864M |
| December 31, 2020 | -3.737M |
| September 30, 2020 | -3.966M |
| June 30, 2020 | -2.952M |
| March 31, 2020 | -4.983M |
| December 31, 2019 | -5.629M |
| September 30, 2019 | -4.554M |
| June 30, 2019 | -4.744M |
| March 31, 2019 | -5.681M |
| December 31, 2018 | 6.030M |
| September 30, 2018 | -4.27M |
| June 30, 2018 | -4.255M |
| March 31, 2018 | -4.685M |
| Date | Value |
|---|---|
| December 31, 2017 | -4.226M |
| September 30, 2017 | -5.107M |
| June 30, 2017 | -4.196M |
| March 31, 2017 | -3.151M |
| December 31, 2016 | -4.676M |
| September 30, 2016 | -4.728M |
| June 30, 2016 | -4.271M |
| March 31, 2016 | -4.766M |
| December 31, 2015 | -3.900M |
| September 30, 2015 | -5.374M |
| June 30, 2015 | -5.686M |
| March 31, 2015 | -5.980M |
| December 31, 2014 | -6.784M |
| September 30, 2014 | -6.115M |
| June 30, 2014 | -4.303M |
| March 31, 2014 | -4.823M |
| December 31, 2013 | -3.466M |
| September 30, 2013 | -2.662M |
| June 30, 2013 | -5.245M |
| March 31, 2013 | 1.790M |
| December 31, 2012 | -6.210M |
| September 30, 2012 | -5.264M |
| June 30, 2012 | -5.378M |
| March 31, 2012 | -5.906M |
| December 31, 2011 | -4.684M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-8.032M
Minimum
Mar 2022
-2.713M
Maximum
Jun 2021
-4.791M
Average
-4.728M
Median
Free Cash Flow (Quarterly) Benchmarks
| Avalo Therapeutics Inc | -6.202M |
| iBio Inc | -3.654M |
| Ocugen Inc | -12.95M |
| Petros Pharmaceuticals Inc | -1.135M |
| NovaBay Pharmaceuticals Inc | -1.574M |